Rozerem and Cefdinir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rozerem (ramelteon) and Cefdinir (cefdinir). Common drug interactions include fatigue among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Rozerem and Cefdinir. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Rozerem?

Rozerem has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 7,539 Rozerem users. Check the latest studies of Rozerem.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

On Jul, 19, 2026

24 people who take Rozerem and Cefdinir together, and have interactions are studied.

What are the common drug interactions of Rozerem and Cefdinir, by gender? *:

female:

Fatigue (feeling of tiredness)
Flatulence (flatus expelled through the anus)
Gastritis (inflammation of stomach)
Hallucination (an experience involving the perception of something not present)
Intestinal polyp (small growths in the bowel with the potential for further growth)
Left ventricular dysfunction
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)

male:

Anaemia (lack of blood)
Haematochezia (passage of stools containing blood)
Chronic kidney disease
Hypokalaemia (low potassium)
Nephritis (inflammation of the nephrons in the kidneys)
Renal failure (kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)
Death
Disease progression
Dopamine dysregulation syndrome (complication of the dopaminergic treatment in parkinson's disease)

What are the common drug interactions of Rozerem and Cefdinir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Altered state of consciousness (altered state of mind)
Blood creatine phosphokinase increased
Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
Oculogyric crisis (a spasmodic movement of the eyeballs into a fixed position due to medicine reaction)
Platelet count decreased
Renal failure acute (rapid kidney dysfunction)

40-49:

Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Pelvic pain
Therapeutic response unexpected
Chronic kidney disease
Dopamine dysregulation syndrome (complication of the dopaminergic treatment in parkinson's disease)
Nausea (feeling of having an urge to vomit)
Neuropathy peripheral (surface nerve damage)

50-59:

Chronic kidney disease
Surgery

60+:

Aggression
Anaemia (lack of blood)
Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
Peripheral vascular disorder
Renal failure acute (rapid kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
Ventricular fibrillation (abnormally irregular heart rhythm)
Weight decreased

What are the existing conditions these people have? *

Infection: 7 people, 29.17%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 25.00%
Arrhythmias (irregular heartbeat): 5 people, 20.83%
Asthma: 4 people, 16.67%
Migraine (headache): 4 people, 16.67%
Hypersensitivity: 4 people, 16.67%
Fungal Infection: 4 people, 16.67%
Fluid Retention (an abnormal accumulation of fluid in the blood): 4 people, 16.67%
Inflammation: 4 people, 16.67%
Pain: 4 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rozerem and Cefdinir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously